• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Catalent Biologics Completes Madison Expansion

    Lonza Expands PyroTec PRO for Endotoxin Testing

    FDA Accepts Airway Therapeutics’ IND for COVID Treatment

    Sanofi Invests in Cutting Edge Vax Production Site in Singapore

    Lilly Modifies Purchase Agreement with U.S. for COVID Therapies
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Catalent Biologics Completes Madison Expansion

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Catalent Biologics Completes Madison Expansion

    Lonza Expands PyroTec PRO for Endotoxin Testing

    FDA Accepts Airway Therapeutics’ IND for COVID Treatment

    Sanofi Invests in Cutting Edge Vax Production Site in Singapore

    Digitalization and the Future of Formulating in Modern R&D Labs
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Reed-Lane

    Quotient Sciences

    PCI Pharma Services

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    PCI Pharma Services

    Almac Group

    Adare Pharma Solutions

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Contract Pharma’s 20th Anniversary Series: Clinical Supply

    Technology plays a big role in clinical trials, supplies, and the rise of patient-centricity

    Contract Pharma’s 20th Anniversary Series: Clinical Supply
    Related CONTENT
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Catalent Pharma Solutions
    • Mogene
    • Regis Custom Pharma
    Kristin Brooks, Contract Pharma10.29.19
    While historically dubbed slow to change, the pharma/biopharma industry has made strides during these past 20 years. Advanced IT and data solutions are addressing today’s increasingly complex drug research and development challenges, improving forecasting of high-value clinical trial materials, and enhancing patient-centricity through mobile platforms.
     
    Over the years, pharma and biopharma companies have increasingly relied on contract service providers for skilled and flexible services in these areas.
     
    Frank Lis, President, Sharp Clinical Services, and Ian Morgan, General Manager, Sharp Clinical Service UK discuss how the industry has evolved, advances in clinical trials, and where we can expect to see changes on the horizon. –KB
     
     
    Contract Pharma: What were some of the major industry changes in the past 20 years that have greatly impacted clinical trials?       
                                                           
    Frank Lis: The proliferation and adoption of technologies has had a huge impact on every party involved in clinical trials. 20 years ago, data gathering was done manually, using a lot of paper, spreadsheets and time. The introduction of things like interactive response technology (IRT) has changed that with the use computer-controlled supply systems to automate drug dispensing and manage site inventories. The practice is becoming more common because it allows for less waste within the supply chain and gives companies a tighter handle on the amount of drug used – making significant savings long the way.
     
    At the other end of the supply chain, we see the rise of patient-centricity. Patients are now so connected through the internet and are drawing on the increasing influence of patient groups to become more involved in all aspects of their clinical trials. They’re forming support groups to discuss their disease and share available treatment options and these support groups will often continue long after the trial. There is a growing focus on having patients use their own devices – such as smartphones – to keep detailed diaries of their trial participation.
     
    Pharma and Biotechs are similarly using mobile platforms and messaging to increase patient recruitment ahead of trials and then keep patients on track throughout. This can offer cost-savings and improves recruitment as well as patient adherence as mobile apps remind them about appointments, when to take drugs and even provide personalized guidance.
     
    CP: What are some changes you anticipate for the future of the industry and outsourcing?
     
    Ian Morgan: There are four core areas where the most change will be seen:
     
    1. The rise of patient-centric practices
    The concept of patient-centric clinical trials – where the participants are active collaborators in the trial and not merely the subject – is nothing new. However, genuine patient-centric trial practice is now really taking a step forward. The major pharmaceutical companies like GSK, Pfizer and Bayer have continued to promote patient centricity, finding new and innovative ways to engage and inform patients.
     
    2. eHealth and data sharing across the EU
    The increasing focus on transparency of clinical trials for patients has been matched by a commitment to the security of patient and trial information. Those in Europe engaged in clinical trials have most recently adjusted to the impacts of the General Data Protection Regulation last May and are now getting themselves ready for the introduction of the new EU Clinical Trials Regulation in 2019.
     
    As well as the regulatory challenges, developments like the European Medicines Agency’s Clinical Data website are increasing the greater transparency of data across the research community.
     
    3. mHealth and Wearable Tech
    Wearable technologies are not widely accepted for clinical trials, but there have been significant steps taken as legislators focused on tackling the current lack of regulatory guidance for their use.
     
    In July 2017, the FDA’s Centre for Devices and Radiologic Health released its Digital Health Innovation Action Plan committing it to develop and implement regulatory strategies and policies for digital health technologies. It follows from the European Commission’s Smart Wearables paper that discusses similar issues.  It’s only a matter of time before they start to be used.
     
    More virtual clinical studies will be enabled by ever-improving technology.
     
    4) Automated clinical trial supplies
    The clinical trials consumables market is set to grow at 5% per-year between 2017-2021, and it’s going to change too. As trial managers seek to improve efficiencies in trial processes to save valuable resources, they are increasingly turning to the automation of clinical trial supplies.

    The complexity of modern clinical trials increases exponentially when conducted across multiple-sites and across various countries. An increasingly pro-active approach to managing clinical trial ancillaries has become a key driver for cost-saving in trials, and continues the trend toward automation.
     
    CP: What global market changes have had the greatest impact on the industry and the services sector?

    Frank Lis: The notable shift in the drug development pipeline from searching for the next ‘blockbuster’ to a focus on high value therapies for rare and orphan diseases has arguably had the biggest impact on the industry. Trials are smaller, products are more expensive and manufactured in lower volumes and tend to have unique supply chain challenges. The FDA is also trying to be more flexible and reduce the amount of time it takes to get products to market specifically with rare and orphan disease. Contract services providers in turn have to be quicker in our response to study demands.
     
    To give a rudimentary example, trial sponsors would traditionally overstock product by about 20% on overage to allow for flexibility in enrollment, retention and supply demand and just throw a lot of product in the bin when it wasn’t used. Now we’re talking about cell-based and biologic therapies with $10,000 plus vials so enrolment and forecasting has to be better and so does the supply chain. Things like Just in Time (JIT) labelling are key as well as they prevent overages.
     
    We’re also seeing virtual pharma start-ups being used to supplement the R&D programs of large pharma. Virtual companies are propped up by private equity and venture capital in the early phases of discovery development and even phase I trial with large pharma stepping it when there’s positive early results.
     
    Contract partners then have had to become more consultative to support these companies that often have no experience in developing and delivering clinical trials.
     
    The downsizing of R&D departments in big pharma has also contributed to a proliferation of consultants in our industry. These independent consultants are highly sought after by smaller virtual start-ups, for their experience, connections and knowledge.
     
    Finally, the push for patient-centricity is forcing change. ‘Virtual clinical trials’ where patients are managed remotely using digital platforms mandate for direct to patient (DTP) trials and this poses a challenge to logistics providers. Similarly, it’s becoming more prevalent for nurses to visit patient homes and for them to use tech (smartphones) to record diaries and perform check-ins (Skype). This will only grow and CROs, CDMOs and the like have had to start developing more partnerships with patient services providers to ensure they can offer the more comprehensive service required.
    Related Searches
    • supply chain
    • orphan
    • Clinical Trials
    • pfizer
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Mogene Mogene
    Regis Custom Pharma Regis Custom Pharma
    Mikart Mikart's Gus Labella
    Exelead Exelead's Alex Aust
    Alcami Alcami's Brittany Jackway
    Federal Equipment Federal Equipment's Adam Covitt
    Sharp Clinical Opens CoE Sharp Clinical Opens CoE
    Contract Pharma’s 20th Anniversary Series: CDMO Insight Contract Pharma’s 20th Anniversary Series: CDMO Insight
    Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Altasciences Altasciences
    Adare Pharma Solutions Adare Pharma Solutions
    Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success! Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!

    Related Online Exclusives

    • Clinical Trials | Drug Development | QA/QC
      RBQM Comes of Age: COVID as a Catalyst for Change

      RBQM Comes of Age: COVID as a Catalyst for Change

      Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.
      Kristin Brooks, Managing Editor 04.01.21

    • Biologics, Proteins, Vaccines | Clinical Trials
      Inside a COVID Vaccine Trial

      Inside a COVID Vaccine Trial

      Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.
      Kristin Brooks, Managing Editor 02.05.21

    • Clinical Trials | Information Technology
      The State of Clinical Trial Technology

      The State of Clinical Trial Technology

      Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.
      Kristin Brooks, Contract Pharma 01.26.21


    • Clinical Trials | Drug Development | Information Technology
      Advancing Digital Endpoints in Clinical Trials

      Advancing Digital Endpoints in Clinical Trials

      An end-to-end approach to managing wearable devices through clinical development.
      Kristin Brooks, Contract Pharma 12.14.20

    • Clinical Trials | Drug Development | Preclinical Outsourcing
      Accelerating R&D Trends

      Accelerating R&D Trends

      The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.
      Kristin Brooks, Contract Pharma 10.20.20

    • Drug Development | Information Technology
      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Trade Secret Litigation: Vulnerabilities Within Pharma Amid Hacking Efforts

      Theft of IP belonging to companies developing biologics and other drugs, including COVID-19 treatments and vaccines, poses a threat to innovation.
      Kristin Brooks, Contract Pharma 08.19.20


    • Drug Development | Information Technology
      Advancing AI Initiatives in R&D

      Advancing AI Initiatives in R&D

      Richard Lee of ACD/Labs discusses the possibilities of using AI in R&D, and what this outlook means for IT leaders at pharmaceutical organizations.
      Kristin Brooks, Contract Pharma 06.11.20

    • Clinical Trials
      Impact of COVID-19 on Winning New Business

      Impact of COVID-19 on Winning New Business

      WuXi Clinical’s Vice President of Biometrics, David Ng, talks about the impact of COVID-19 on clinical trials and business relations
      Tim Wright, Editor, Contract Pharma 06.03.20

    • APIs | cGMP Manufacture | Clinical Trials | Supply Chain
      Evaluating Pharma Amid COVID-19

      Evaluating Pharma Amid COVID-19

      Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformation
      Kristin Brooks, Contract Pharma 05.18.20


    • Clinical Trials
      Pioneering Medicine Forward

      Pioneering Medicine Forward

      May 20th marks Clinical Trials Day, celebrating 273 years of clinical trials
      Tina Bland, Senior Consultant, KCR Trial Execution Consulting 05.18.20

    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      CRO Industry Update

      CRO Industry Update

      Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
      Kristin Brooks, Contract Pharma 04.27.20

    • Clinical Trials | Information Technology | QA/QC
      Managing Clinical Trials Amid the Coronavirus Pandemic

      Managing Clinical Trials Amid the Coronavirus Pandemic

      Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.
      Kristin Brooks, Contract Pharma 04.06.20


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer
      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines
      Kristin Brooks, Contract Pharma 04.03.20

    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      COVID-19 Vaccine Response

      COVID-19 Vaccine Response

      ICON execs discuss developments in vaccine research efforts and key challenges of delivering a coronavirus vaccine
      Kristin Brooks, Contract Pharma 04.01.20

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development
      COVID-19 Clinical Trials

      COVID-19 Clinical Trials

      The vaccines in development for COVID-19, who's developing them, and where they stand in the development process
      Kristin Brooks, Contract Pharma 03.10.20

    Trending
    • Astellas, Affinivax In Global MAPS Vax Pact
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Catalent Biologics Completes Madison Expansion
    • ANI Acquires Branded Products Portfolio From Sandoz
    Breaking News
    • Catalent Biologics Completes Madison Expansion
    • Lonza Expands PyroTec PRO for Endotoxin Testing
    • FDA Accepts Airway Therapeutics’ IND for COVID Treatment
    • Sanofi Invests in Cutting Edge Vax Production Site in Singapore
    • Lilly Modifies Purchase Agreement with U.S. for COVID Therapies
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    4-week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’
    KD Pharma Acquires Rohner AG Manufacturing Assets
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Sika Expands Production Capacity in Qatar
    Sto Corp. ISO Certifications Extended
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MICRO Expands with New Facility in Costa Rica
    DiaSorin to Buy Luminex for $1.8B
    Endologix Acquires PQ Bypass
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catalent Biologics Completes Madison Expansion
    Lonza Expands PyroTec PRO for Endotoxin Testing
    FDA Accepts Airway Therapeutics’ IND for COVID Treatment
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revieve Launches Skin Coach
    Carlyle Group Acquires Majority Stake in Beautycounter
    The Honest Co. Files for an Initial Public Offering
    Happi

    Latest Breaking News From Happi

    Babor Professional Skin Care Names McCaffrey as Vice President of Sales
    Diamond Chemical Appoints Technical Service Representative
    Carlyle To Acquire Majority Stake in Beautycounter
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Enprom helps converter respond to flexible packaging needs
    anytron assists medical device company with labeling
    Dantex debuts new capabilities with white ink opacity
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Aries Face Masks Meet ASTM Standards
    Tufropes Launches Inherently Antibacterial and Antimicrobial Spunbond
    NXTNano Adding Three Lines
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    First Solar Series 6 CuRe has Industry’s Lowest Warranted Degradation Rate
    SEMI: 2020 Global Semiconductor Equipment Sales Surge 19% to Industry Record $71.2 Billion

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login